This review examines some interesting 'new' histories of insulin and reviews our current understanding of its physiological actions and synergy with GH in the regulation of metabolism and body composition. It reviews the history of GH abuse that antedates by many years the awareness of endocrinologists to its potent anabolic actions. Promising methods for detection of GH abuse have been developed but have yet to be sufficiently well validated to be ready for introduction into competitive sport. So far, there are two promising avenues for detecting GH abuse. The first uses immunoassays that can distinguish the isomers of pituitary-derived GH from the monomer of recombinant human GH. The second works through demonstrating circulating concentrations of one or more GH-sensitive substances that exceed the extremes of normal physiological variability. Both methods require blood rather than urine samples. The first method has a window of opportunity lasting about 24 h after an injection and is most suitable for 'out of competition' testing. The second method has reasonable sensitivity for as long as 2 weeks after the last injection of GH and is uninfluenced by extreme exercise and suitable for post-competition samples. This method has a greater sensitivity in men than in women. The specificity of both methods seems acceptably high but lawyers need to decide what level of scientific probability is needed to obtain a conviction. Both methods need further validation before implementation. Research work carried out as part of the fight against doping in sport has opened up a new and exciting area of endocrinology.
CiteULike    Complore    Connotea    Delicious    Digg    Facebook    LinkedIn    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				L. Di Luigi, A. E Rigamonti, F. Agosti, M. Mencarelli, P. Sgro, N. Marazzi, S. G Cella, E. E Muller, and A. Sartorio Combined evaluation of resting IGF1, N-terminal propeptide of type III procollagen and C-terminal cross-linked telopeptide of type I collagen levels might be useful for detecting inappropriate GH administration in female athletes Eur. J. Endocrinol., May 1, 2009; 160(5): 753 - 758. [Abstract] [Full Text] [PDF]

				I. Erotokritou-Mulligan, E. E. Bassett, C. Bartlett, D. Cowan, C. McHugh, R. Seah, B. Curtis, V. Wells, K. Harrison, P. H. Sonksen, et al. The Effect of Sports Injury on Insulin-Like Growth Factor-I and Type 3 Procollagen: Implications for Detection of Growth Hormone Abuse in Athletes J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2760 - 2763. [Abstract] [Full Text] [PDF]

				L. Chung, D. Clifford, M. Buckley, and R. C. Baxter Novel Biomarkers of Human Growth Hormone Action from Serum Proteomic Profiling Using Protein Chip Mass Spectrometry J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 671 - 677. [Abstract] [Full Text] [PDF]

				J Jurimae and T Jurimae Leptin responses to short term exercise in college level male rowers Br. J. Sports Med., January 1, 2005; 39(1): 6 - 9. [Abstract] [Full Text] [PDF]

				R. L Hintz Growth hormone: uses and abuses BMJ, April 17, 2004; 328(7445): 907 - 908. [Full Text] [PDF]

				Medical aspects of drug use in the gym DTB, January 1, 2004; 42(1): 1 - 5. [Abstract] [Full Text] [PDF]